Synthetic short RNA in cancer

1

Synthetic short RNAs, including siRNAs and aptamers, are crucial tools for modulating cellular biology and have significant anti-tumor potential.
2

RNA-based therapies offer high versatility and druggability compared to traditional treatments, but face challenges in stability and delivery.
3

Synthetic short mRNAs are a new category of RNA-based therapy, designed to combat cancer by utilizing sequences from extracellular mRNA.
4

In vitro sequence selection techniques like SELEX enable efficient screening of oligonucleotide sequences for optimized therapeutic applications.
5

Chemical modifications of synthetic short RNAs enhance their stability and efficacy, making them more effective in targeting cancer cells.

1